4
Changes in Ownership
SAB Biotherapeutics, Inc. Filed Acc 0000899243-22-011662
Options or other derivatives
- Chief Communications Officer acquired 16,405 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Ullerich Melissa Vera · Chief Communications Officer
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2022-03-16 | Grant or award : show line 1 in the form Employee Stock Option (right to buy) | +16,405 | 16,405 | D |
Loading xslF345X03/doc4.xml…